TickerFacts.

Bioventus Inc. (BVS): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$455.11M
As of 2025-12-31
$395.93M
As of 2026-06-27
-22.0%
3-year compound annual growth
$960.43M2020-12-31: $350.31M2021-12-31: $618.21M2022-12-31: $960.43M2023-12-31: $589.79M2024-12-31: $542.35M2025-12-31: $455.11M$455.11M
2020-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$455.11M-16.1%2026-03-05, Balance as of period end
2024-12-31$542.35M-8.0%2026-03-05, Balance as of period end
2023-12-31$589.79M-38.6%2025-03-11, Balance as of period end
2022-12-31$960.43M+55.4%2024-03-12, Balance as of period end
2021-12-31$618.21Mn/c2024-03-12, Balance as of period end
2020-12-31$350.31Mn/a2022-03-11, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Bioventus Inc. (BVS)2025-12-31$455.11M-16.1%
UFP Technologies Inc (UFPT)2025-12-31$231.20M-19.2%
AtriCure, Inc. (ATRC)2025-12-31$162.24M+9.4%
Glaukos Corp (GKOS)2025-12-31$237.33M+14.2%
NovoCure Ltd (NVCR)2025-12-31$463.86M-47.3%
Artivion, Inc. (AORT)2025-12-31$436.56M-14.9%
iRhythm Holdings, Inc. (IRTC)2025-12-31$867.30M+3.2%
Mimedx Group, Inc. (MDXG)2025-12-31$86.11M+21.6%
Accuray Inc (ARAY)2026-06-30$401.98M+3.3%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗